521 related articles for article (PubMed ID: 30793421)
1. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Krebs MO; Kebir O; Jay TM
Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
[TBL] [Abstract][Full Text] [Related]
2. [Cannabis and cannabinoids as drugs].
Khiabani HZ; Mørland J
Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.
Levine A; Clemenza K; Rynn M; Lieberman J
J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):214-225. PubMed ID: 28219487
[TBL] [Abstract][Full Text] [Related]
4. Individual and combined effects of cannabidiol and Δ
Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA
J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578
[TBL] [Abstract][Full Text] [Related]
5. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
Spanagel R; Bilbao A
Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
[TBL] [Abstract][Full Text] [Related]
6. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness].
Sagie S; Eliasi Y; Livneh I; Bart Y; Monovich E
Harefuah; 2013 Dec; 152(12):737-41, 751. PubMed ID: 24483000
[TBL] [Abstract][Full Text] [Related]
7. The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.
Borgan F; Beck K; Butler E; McCutcheon R; Veronese M; Vernon A; Howes OD
Psychopharmacology (Berl); 2019 Nov; 236(11):3257-3270. PubMed ID: 31165913
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
9. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
[TBL] [Abstract][Full Text] [Related]
10. Cannabis-associated psychosis: Neural substrate and clinical impact.
Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
[TBL] [Abstract][Full Text] [Related]
11. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
Morgan CJ; Gardener C; Schafer G; Swan S; Demarchi C; Freeman TP; Warrington P; Rupasinghe I; Ramoutar A; Tan N; Wingham G; Lewis S; Curran HV
Psychol Med; 2012 Feb; 42(2):391-400. PubMed ID: 21798112
[TBL] [Abstract][Full Text] [Related]
12. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
van Amsterdam J; Brunt T; van den Brink W
J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
14. [Cannabis-induced cognitive and psychiatric disorders].
Dervaux A; Krebs MO; Laqueille X
Bull Acad Natl Med; 2014 Mar; 198(3):559-74; discussion 575-7. PubMed ID: 26427297
[TBL] [Abstract][Full Text] [Related]
15. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation.
Lamanna-Rama N; Romero-Miguel D; Casquero-Veiga M; MacDowell KS; Santa-Marta C; Torres-Sánchez S; Berrocoso E; Leza JC; Desco M; Soto-Montenegro ML
Psychiatry Res; 2024 Jan; 331():115643. PubMed ID: 38064909
[TBL] [Abstract][Full Text] [Related]
16. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
Cohen M; Solowij N; Carr V
Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids and Psychosis.
D'Souza DC; Radhakrishnan R; Sherif M; Cortes-Briones J; Cahill J; Gupta S; Skosnik PD; Ranganathan M
Curr Pharm Des; 2016; 22(42):6380-6391. PubMed ID: 27568729
[TBL] [Abstract][Full Text] [Related]
18. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.
Realini N; Rubino T; Parolaro D
Pharmacol Res; 2009 Aug; 60(2):132-8. PubMed ID: 19559364
[TBL] [Abstract][Full Text] [Related]
19. Human Laboratory Studies on Cannabinoids and Psychosis.
Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
[TBL] [Abstract][Full Text] [Related]
20. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Lötsch J; Weyer-Menkhoff I; Tegeder I
Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
